TABLE 4.
Relationship Between Clinicopathologic Characteristics and Patients With or Without 68Ga-PSMA−, 18F-FDG+ Lesions
| 68Ga-PSMA−, 18F-FDG+ lesions | ||||
|---|---|---|---|---|
| Variable | Total (n) | No | Yes | P |
| Age (y) | ||||
| <70 | 31 | 23 | 8 | 0.609 |
| ≥70 | 25 | 20 | 5 | |
| PSA doubling time (mo) | ||||
| <6 | 29 | 22 | 7 | 0.203 |
| ≥6 | 27 | 24 | 3 | |
| PSA level (ng/mL) | 56 | 7.5 ± 2.5 | 20.8 ± 8.3 | 0.040 |
| ADT duration time (mo) | 56 | 16.8 ± 2.5 | 28.0 ± 5.1 | 0.238 |
| Two-scan interval (d) | 56 | 7.4 ± 0.8 | 6.9 ± 2.0 | 0.806 |
| Median Gleason score | 56 | 7 (IQR, 7–9) | 9 (IQR, 8–9) | <0.001 |
IQR = interquartile range.